Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Vor Biopharma Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- +5 vs. Q2 2021
- Shares held
- 30.7M
- +991.3K (+3.3%) vs. Q2 2021
- Total value
- $481.2M
- −$69.9M (−12.7%) vs. Q2 2021
- New holders
- 9
- 24 more added
- Sold out
- 4
- 14 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 11,120,973 | $174.4M | 2.42% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 6,692,429 | $104.9M | 21.31% | 00.0% | Unchanged |
| FMR LLC | 3,205,394 | $50.3M | 0.00% | −355,797−10.0% | Reduced |
| Vanguard Group Inc | 1,301,056 | $20.4M | 0.00% | +457,673+54.3% | Added |
| BlackRock Inc. | 1,130,038 | $17.7M | 0.00% | +356,413+46.1% | Added |
| Woodline Partners LP | 1,111,123 | $17.4M | 0.29% | −35,371−3.1% | Reduced |
| Johnson & Johnson | 1,074,658 | $16.9M | 1.48% | +1,074,658 | New |
| OrbiMed Advisors LLC | 833,333 | $13.1M | 0.15% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 707,010 | $11.1M | 0.87% | 00.0% | Unchanged |
| Laurion Capital Management LP | 657,308 | $10.3M | 0.15% | +71,641+12.2% | Added |
| Artal Group S.A. | 550,000 | $8.62M | 0.21% | 00.0% | Unchanged |
| Thrivent Financial for Lutherans | 303,798 | $4.76M | 0.01% | +25,318+9.1% | Added |
| Geode Capital Management, LLC | 271,937 | $4.26M | 0.00% | +77,211+39.7% | Added |
| Putnam Investments LLC | 238,438 | $3.74M | 0.01% | −311,562−56.6% | Reduced |
| State Street Corp | 236,123 | $3.70M | 0.00% | +34,320+17.0% | Added |
| JPMorgan Chase & Co | 227,824 | $3.57M | 0.00% | +217,202+2,044.8% | Added |
| Northern Trust Corp | 153,051 | $2.40M | 0.00% | +42,073+37.9% | Added |
| Parametric Portfolio Associates LLC | 137,013 | $2.15M | 0.00% | +51,382+60.0% | Added |
| Gilder Gagnon Howe & Co LLC | 110,241 | $1.73M | 0.01% | −170,434−60.7% | Reduced |
| Trustees of Columbia University in the City of New York | 91,910 | $1.44M | 2.20% | −91,911−50.0% | Reduced |
| Charles Schwab Investment Management Inc | 89,456 | $1.40M | 0.00% | +20,426+29.6% | Added |
| Nuveen Asset Management, LLC | 58,523 | $899.0K | 0.00% | +10,321+21.4% | Added |
| Bollard Group LLC | 55,555 | $871.0K | 0.03% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 52,251 | $819.0K | 0.00% | +18,288+53.8% | Added |
| Morgan Stanley | 51,614 | $809.0K | 0.00% | −60,844−54.1% | Reduced |
| Parkwood LLC | 49,335 | $774.0K | 0.13% | −1,397−2.8% | Reduced |
| Bank of America Corp | 20,249 | $318.0K | 0.00% | +1,307+6.9% | Added |
| Chicago Partners Investment Group LLC | 18,868 | $316.0K | 0.02% | −11,918−38.7% | Reduced |
| Rhumbline Advisers | 15,406 | $242.0K | 0.00% | +3,869+33.5% | Added |
| State of Wisconsin Investment Board | 14,800 | $232.0K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 14,005 | $220.0K | 0.00% | +14,005 | New |
| Deutsche Bank AG | 11,233 | $176.0K | 0.00% | +3,954+54.3% | Added |
| SG Americas Securities, LLC | 10,868 | $170.0K | 0.00% | +10,868 | New |
| American International Group, Inc. | 10,385 | $163.0K | 0.00% | +3,992+62.4% | Added |
| California State Teachers Retirement System | 10,252 | $161.0K | 0.00% | −5,494−34.9% | Reduced |
| Virtus ETF Advisers LLC | 9,533 | $149.0K | 0.07% | −493−4.9% | Reduced |
| MetLife Investment Management | 8,268 | $129.6K | 0.00% | +8,268 | New |
| New York State Common Retirement Fund | 7,806 | $122.0K | 0.00% | −3,486−30.9% | Reduced |
| Metropolitan Life Insurance Co | 6,255 | $98.1K | 0.00% | +6,255 | New |
| Bourgeon Capital Management LLC | 6,053 | $95.0K | 0.02% | +4,250+235.7% | Added |
| STRS Ohio | 2,700 | $42.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,165 | $34.0K | 0.00% | +1,623+299.4% | Added |
| The PNC Financial Services Group, Inc. | 2,000 | $31.0K | 0.00% | +1,000+100.0% | Added |
| Royal Bank of Canada | 1,902 | $30.0K | 0.00% | +1,121+143.5% | Added |
| Legal & General Group Plc | 1,553 | $24.0K | 0.00% | +582+59.9% | Added |
| Ameritas Investment Partners, Inc. | 1,483 | $23.0K | 0.00% | +555+59.8% | Added |
| Tower Research Capital LLC (TRC) | 730 | $11.0K | 0.00% | −202−21.7% | Reduced |
| Northwestern Mutual Wealth Management Co | 250 | $4.00K | 0.00% | +250 | New |
| Signaturefd, LLC | 159 | $2.00K | 0.00% | +97+156.5% | Added |
| US Bancorp | 112 | $2.00K | 0.00% | +112 | New |
| UBS Group AG | 37 | $1.00K | 0.00% | −5,081−99.3% | Reduced |
| Parallel Advisors, LLC | 88 | $1.00K | 0.00% | +40+83.3% | Added |
| Captrust Financial Advisors | 37 | $1.00K | 0.00% | +37 | New |
| Wells Fargo & Company | 30 | $0 | 0.00% | −59−66.3% | Reduced |
| Ellevest, Inc. | 10 | $0 | 0.00% | +10 | New |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −405,324−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −18,339−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |